Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Read now
. (2020) ALSUntangled 53: Carnitine supplements. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 477-483.
Read now
Read now
Débora Lanznaster, Theodora Bejan-Angoulvant, Franck Patin, Christian R. Andres, Patrick Vourc’h, Phillipe Corcia & HÉlÉne Blasco. (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 199-206.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
. (2018) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 198-216.
Read now
Read now
Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
Read now
Zhouwei Xu, Aven Lee, Amanda Nouwens, Robert David Henderson & Pamela Ann McCombe. (2018) Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 362-376.
Read now
Read now
Rebecca Traub & Hiroshi Mitsumoto. (2016) Recent advances and opportunities for improving diagnosis of amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 4:9, pages 907-915.
Read now
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Read now
Elizabeth Gray, James R. Larkin, Tim D. W. Claridge, Kevin Talbot, Nicola R. Sibson & Martin R. Turner. (2015) The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 456-463.
Read now
Read now
Articles from other publishers (55)
Sandeep C Pingle, Feng Lin, Misa S Anekoji, C Pawan K Patro, Souvik Datta, Lawrence D Jones, Santosh Kesari & Shashaanka Ashili. (2023) Exploring the role of cerebrospinal fluid as analyte in neurologic disorders. Future Science OA 9:4.
Crossref
Crossref
Stephen A. Goutman, Jonathan Boss, Gayatri Iyer, Hani Habra, Masha G. Savelieff, Alla Karnovsky, Bhramar Mukherjee & Eva L. Feldman. (2022) Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle & Nerve 67:3, pages 208-216.
Crossref
Crossref
Maruša Barbo & Metka Ravnik-Glavač. (2023) Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes 14:2, pages 325.
Crossref
Crossref
Winanto Ng & Shi-Yan Ng. (2022) Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity. Translational Neurodegeneration 11:1.
Crossref
Crossref
Stephen A Goutman, Kai Guo, Masha G Savelieff, Adam Patterson, Stacey A Sakowski, Hani Habra, Alla Karnovsky, Junguk Hur & Eva L Feldman. (2022) Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts. Brain 145:12, pages 4425-4439.
Crossref
Crossref
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz & J. Alex Parker. (2022) Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 5:1.
Crossref
Crossref
Fay Probert, Anna Gorlova, Alexei Deikin, Lucien Bettendorff, Ekaterina Veniaminova, Andrey Nedorubov, Kirill D. Chaprov, Tamara A. Ivanova, Daniel C. Anthony & Tatyana Strekalova. (2022) In FUS[1−359]‐tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome. Biomedicine & Pharmacotherapy 156, pages 113986.
Crossref
Crossref
Ira Agrawal, Yong Shan Lim, Shi-Yan Ng & Shuo-Chien Ling. (2022) Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Translational Neurodegeneration 11:1.
Crossref
Crossref
Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey, Patrick Emond & Hélène Blasco. (2022) Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases. Metabolites 12:9, pages 864.
Crossref
Crossref
Gavin McCluskey, Colette Donaghy, Karen E. Morrison, John McConville, William Duddy & Stephanie Duguez. (2022) The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. Journal of Personalized Medicine 12:9, pages 1418.
Crossref
Crossref
Zhicheng Liu, Jeffrey Waters & Bin Rui. (2022) Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances. Biomedical Journal 45:4, pages 594-606.
Crossref
Crossref
Tomoko Nakazato, Kazuaki Kanai, Tetsushi Kataura, Shuko Nojiri, Nobutaka Hattori & Shinji Saiki. (2022) Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis. Scientific Reports 12:1.
Crossref
Crossref
Mukesh Gautam, Aksu Gunay, Navdeep S. Chandel & P. Hande Ozdinler. (2022) Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy. Scientific Reports 12:1.
Crossref
Crossref
Suvithanandhini Loganathan, Bryce A. Wilson, Sara B. Carey, Ernesto Manzo, Archi Joardar, Berrak Ugur & Daniela C. Zarnescu. (2022) TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS. Metabolites 12:2, pages 101.
Crossref
Crossref
Kuo-Hsuan Chang, Chia-Ni Lin, Chiung-Mei Chen, Rong-Kuo Lyu, Chun-Che Chu, Ming-Feng Liao, Chin-Chang Huang, Hong-Shiu Chang, Long-Sun Ro & Hung-Chou Kuo. (2021) Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis. Biomedicines 9:12, pages 1944.
Crossref
Crossref
Hojae Lee, Jae Jin Lee, Na Young Park, Sandeep Kumar Dubey, Taeyong Kim, Kai Ruan, Su Bin Lim, Seong-Hyun Park, Shinwon Ha, Irina Kovlyagina, Kyung-tai Kim, Seongjun Kim, Yohan Oh, Hyesoo Kim, Sung-Ung Kang, Mi-Ryoung Song, Thomas E. Lloyd, Nicholas J. Maragakis, Young Bin Hong, Hyungjin Eoh & Gabsang Lee. (2021) Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nature Neuroscience 24:12, pages 1673-1685.
Crossref
Crossref
Pratishtha Chatterjee, Yeo‐Jin Cheong, Atul Bhatnagar, Kathryn Goozee, Yunqi Wu, Matthew McKay, Ian J. Martins, Wei L. F. Lim, Steve Pedrini, Michelle Tegg, Victor L. Villemagne, Prita R. Asih, Preeti Dave, Tejal M. Shah, Cintia B. Dias, Stephanie J. Fuller, Heidi Hillebrandt, Sunil Gupta, Eugene Hone, Kevin Taddei, Henrik Zetterberg, Kaj Blennow, Hamid R. Sohrabi & Ralph N. Martins. (2020) Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. Journal of Neurochemistry 159:2, pages 389-402.
Crossref
Crossref
João Morgadinho, Ana Catarina Pronto-Laborinho, Vasco A. Conceição, Marta Gromicho, Susana Pinto, Michael Swash & Mamede de Carvalho. (2021) Plasma Creatinine Level Does Not Predict Respiratory Function in Amyotrophic Lateral Sclerosis. Journal of Neuromuscular Diseases 8:5, pages 795-799.
Crossref
Crossref
Heather M. Wilkins, Mazen M. Dimachkie & Abdulbaki Agbas. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis
105
120
.
Mengmeng Wang, Dandan Liu, Zhizhong Zhang, Wei Xie, Liping Cao, Linfeng Zhu, Meng Liu, Shiying Sheng & Xuegan Lian. (2021) Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study. Molecular Neurobiology 58:6, pages 2910-2915.
Crossref
Crossref
Stephen A Goutman, Jonathan Boss, Kai Guo, Fadhl M Alakwaa, Adam Patterson, Sehee Kim, Masha Georges Savelieff, Junguk Hur & Eva L Feldman. (2020) Untargeted metabolomics yields insight into ALS disease mechanisms. Journal of Neurology, Neurosurgery & Psychiatry 91:12, pages 1329-1338.
Crossref
Crossref
Qiuying Chen, Csaba Konrad, Davinder Sandhu, Dipa Roychoudhury, Benjamin I. Schwartz, Roger R. Cheng, Kirsten Bredvik, Hibiki Kawamata, Elizabeth L. Calder, Lorenz Studer, Steven.M. Fischer, Giovanni Manfredi & Steven.S. Gross. (2020) Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients. Neurobiology of Disease 144, pages 105025.
Crossref
Crossref
Michael S. Bereman, Kaylie I. Kirkwood, Tharani Sabaretnam, Sarah Furlong, Dominic B. Rowe, Gilles J. Guillemin, Allyson L. Mellinger & David C. Muddiman. (2020)
Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-
l
-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis
. Journal of Proteome Research 19:8, pages 3276-3285.
Crossref
Crossref
Can Cui, Jiangwei Sun, Yudi Pawitan, Fredrik Piehl, Honglei Chen, Caroline Ingre, Karin Wirdefeldt, Marie Evans, John Andersson, Juan-Jesus Carrero & Fang Fang. (2020) Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson’s disease. Brain Communications 2:2.
Crossref
Crossref
Débora Lanznaster, Charlotte Veyrat-Durebex, Patrick Vourc’h, Christian R. Andres, Hélène Blasco & Philippe Corcia. (2020) Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis. Genes 11:5, pages 537.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Laura Moreno-Martinez, Ana Cristina Calvo, María Jesús Muñoz & Rosario Osta. (2019) Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?. International Journal of Molecular Sciences 20:11, pages 2759.
Crossref
Crossref
Gavin Pharaoh, Kavithalakshmi Sataranatarajan, Kaitlyn Street, Shauna Hill, Jake Gregston, Bumsoo Ahn, Caroline Kinter, Michael Kinter & Holly Van Remmen. (2019) Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice. Frontiers in Neuroscience 13.
Crossref
Crossref
Udaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, Anthony J. Bjourson, William Duddy & Stephanie Marie-Rose Duguez. (2019) A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Lina Mu, Zhongzheng Niu, Rachael Hageman Blair, Han Yu, Richard W. Browne, Matthew R. Bonner, Tiffany Fanter, Furong Deng & Mya Swanson. (2019) Metabolomics Profiling before, during, and after the Beijing Olympics: A Panel Study of Within-Individual Differences during Periods of High and Low Air Pollution. Environmental Health Perspectives 127:5.
Crossref
Crossref
Kjetil Bjornevik, Zhongli ZhangÉilis J. O'ReillyJames D. BerryClary B. Clish, Amy DeikSarah JeanfavreIkuko KatoRachel S. KellyLaurence N. KolonelLiming LiangLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniKerry A. PierceMichael A. SchwarzschildAladdin H. ShadyabJean Wactawski-WendeDong D. WangYing WangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Crossref
Kjetil BjornevikÉilis J. O'ReillyJames D. BerryClary B. ClishSarah JeanfavreIkuko KatoLaurence N. KolonelLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniMichael A. SchwarzschildEvelyn O. TalbottRobert B. WallaceZhongli ZhangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Chunting Zhang, Yueqing Yang, Weiwei Liang, Tianhang Wang, Shuyu Wang, Xudong Wang, Ying Wang, Hongquan Jiang & Honglin Feng. (2019) Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways. Brain Research Bulletin 146, pages 287-301.
Crossref
Crossref
Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat & Hélène Blasco. (2018) Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. Frontiers in Neurology 9.
Crossref
Crossref
Ernesto Manzo, Abigail G. O'Conner, Jordan M. Barrows, Dakotah D. Shreiner, Gabriel J. Birchak & Daniela C. Zarnescu. (2018) Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink & Leonard H van den Berg. (2018) Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 89:2, pages 156-161.
Crossref
Crossref
Tara Kashav & Vijay Kumar. 2018. Systems Biology. Systems Biology
59
75
.
Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, Wolfgang Koenig, Luc Dupuis, Dietrich Rothenbacher & Albert C. Ludolph. (2017) Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany. Scientific Reports 7:1.
Crossref
Crossref
Archi Joardar, Ernesto Manzo & Daniela C. Zarnescu. (2017) Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Current Genetic Medicine Reports 5:2, pages 108-114.
Crossref
Crossref
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Crossref
Sabrina Paganoni & Michael A. Schwarzschild. (2016) Urate as a Marker of Risk and Progression of Neurodegenerative Disease. Neurotherapeutics 14:1, pages 148-153.
Crossref
Crossref
Andreas Jeromin & Robert Bowser. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
491
528
.
Samanta Gasco, Amaya Rando, Pilar Zaragoza, Alberto García-Redondo, Ana Cristina Calvo & Rosario Osta. (2016) Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis. American Journal of Physiology-Cell Physiology 311:6, pages C910-C919.
Crossref
Crossref
Charlotte Veyrat-Durebex, Philippe Corcia, Eric Piver, David Devos, Audrey Dangoumau, Flore Gouel, Patrick Vourc’h, Patrick Emond, Frédéric Laumonnier, Lydie Nadal-Desbarats, Paul H Gordon, Christian R Andres & Hélène Blasco. (2015) Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis. Molecular Neurobiology 53:10, pages 6910-6924.
Crossref
Crossref
Medi KoriBusra AydınSemra UnalKazim Yalcin ArgaDilek Kazan. (2016) Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. OMICS: A Journal of Integrative Biology 20:11, pages 645-661.
Crossref
Crossref
Junfang Wu, Anna Wuolikainen, Miles Trupp, Pär Jonsson, Stefan L. Marklund, Peter M. Andersen, Lars Forsgren & Anders Öhman. (2016) NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects. Metabolomics 12:6.
Crossref
Crossref
Júlia Costa & Mamede de Carvalho. (2016) Emerging molecular biomarker targets for amyotrophic lateral sclerosis. Clinica Chimica Acta 455, pages 7-14.
Crossref
Crossref
H. Blasco, F. Patin, B. Madji Hounoum, P. H. Gordon, P. Vourc'h, C. R. Andres & P. Corcia. (2016) Metabolomics in amyotrophic lateral sclerosis: how far can it take us?. European Journal of Neurology 23:3, pages 447-454.
Crossref
Crossref
Anna Wuolikainen, Pär Jonsson, Maria Ahnlund, Henrik Antti, Stefan L. Marklund, Thomas Moritz, Lars Forsgren, Peter M. Andersen & Miles Trupp. (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Molecular BioSystems 12:4, pages 1287-1298.
Crossref
Crossref
Diana Caballero-Hernandez, Miguel G. Toscano, Marta Cejudo-Guillen, Maria L. Garcia-Martin, Soledad Lopez, Jaime M. Franco, Francisco J. Quintana, Cintia Roodveldt & David Pozo. (2016) The ‘Omics’ of Amyotrophic Lateral Sclerosis. Trends in Molecular Medicine 22:1, pages 53-67.
Crossref
Crossref
Trayambak Basak, Swati Varshney, Zeeshan Hamid, Sourav Ghosh, Sandeep Seth & Shantanu Sengupta. (2015) Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach. Journal of Proteomics 127, pages 169-177.
Crossref
Crossref
Ilaria Bicchi, Carla Emiliani, Angelo Vescovi & Sabata Martino. (2015) The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics. Neurodegenerative Diseases 15:6, pages 313-321.
Crossref
Crossref
Clara Ibáñez, Alejandro Cifuentes & Carolina Simó. 2015. Omic Studies of Neurodegenerative Disease: Part B. Omic Studies of Neurodegenerative Disease: Part B
95
132
.
Alejandro Botas, Hannah Moore Campbell, Xu Han & Mirjana Maletic-Savatic. 2015. Omic Studies of Neurodegenerative Disease: Part B. Omic Studies of Neurodegenerative Disease: Part B
53
80
.